Benzinga - Tue, 04 May 2021 10:09:11 -0400
Benzinga - Tue, 13 Apr 2021 05:18:31 -0400
Benzinga - Mon, 12 Apr 2021 12:00:14 -0400
load more
VectivBio Holding AG is a clinical stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe rare conditions for which there is a significant unmet medical need. The product candidate is apraglutide, which is a next generation, long-acting synthetic peptide analog of glucagon-like peptide-2, or GLP-2, which is developed as a differentiated therapeutic for a range of rare GI diseases, with an initial focus on short bowel syndrome.

Related Companies

TickerCompanyChg %Mkt Cap
VECTVectivBio Holding-1.89%

VectivBio Holding Company Questions & Answers

Q

How do I buy VectivBio Holding (VECT) stock?

A

You can purchase shares of VectivBio Holding (NASDAQ: VECT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are VectivBio Holding's (VECT) main competitors?

A

There are no as such competitors for VectivBio Holding.

Q

What is the target price for VectivBio Holding?

A

There is no analysis for VectivBio Holding

Q

How much is VectivBio Holding (VECT) stock ?

A

The stock price for VectivBio Holding (NASDAQ: VECT) is $13.5 last updated Fri May 07 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

When is the next VectivBio Holding (VECT) dividend?

A

There are no upcoming dividends for VectivBio Holding.

Q

When is VectivBio Holding (NASDAQ:VECT) reporting earnings?

A

There are no earnings for VectivBio Holding

Q

When is the upcoming split for VECT?

A

There is no upcoming split for VectivBio Holding.